Exelixis Clinical Site #36

Barcelona 08036

0 studies enrolling now · 2 studies all time

What they study most

Cervical Cancer, Endometrial Cancer, Epithelial Ovarian Cancer, Esophageal SCC, Hormone Receptor-positive Breast Cancer, Metastatic Castration-resistant Prostate Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, Renal Cell Carcinoma, SCCHN, Tissue Factor-Expressing Solid Tumors, Triple Negative Breast Cancer

Studies at this site

• Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma — Running, not enrolling
• Study of XB002 in Subjects With Solid Tumors (JEWEL-101) — Completed